Compounds > 14,15-epoxy-5,8,11-eicosatrienoic acid

14,15-epoxy-5,8,11-eicosatrienoic acid and lipoxin a4

14,15-epoxy-5,8,11-eicosatrienoic acid has been researched along with lipoxin a4 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Croze, R; Levy, BD; Pfeffer, MA; Planagumà, A; Rubin, G; Serhan, CN; Uddin, M1
Bahl, CD; Bomberger, JM; Eddens, T; Flitter, BA; Hammock, BD; Hampton, TH; Hvorecny, KL; Kolls, JK; Kwak, DH; Lee, JS; Levy, BD; Liu, X; Madden, DR; Morisseau, C; Ono, E; Yang, J1

Other Studies

2 other study(ies) available for 14,15-epoxy-5,8,11-eicosatrienoic acid and lipoxin a4

ArticleYear
Lovastatin decreases acute mucosal inflammation via 15-epi-lipoxin A4.
    Mucosal immunology, 2010, Volume: 3, Issue:3

    Topics: 8,11,14-Eicosatrienoic Acid; Acute Disease; Animals; Anticholesteremic Agents; Cell Line; Disease Models, Animal; Female; Humans; Hypercholesterolemia; Inflammation; Inflammation Mediators; Lipoxins; Lovastatin; Male; Mice; Neutrophils; Pneumonia; Respiratory Mucosa

2010
Pseudomonas aeruginosa sabotages the generation of host proresolving lipid mediators.
    Proceedings of the National Academy of Sciences of the United States of America, 2017, 01-03, Volume: 114, Issue:1

    Topics: 8,11,14-Eicosatrienoic Acid; Bacterial Proteins; Bronchoalveolar Lavage Fluid; Cell Line; Crystallography, X-Ray; Cystic Fibrosis; Humans; Inflammation; Lipoxins; Lung Diseases; Neutrophil Activation; Neutrophils; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Virulence Factors

2017